5 Australia Day Celebrations In Sydney You Cannot Miss
If you’re in Sydney for Australia Day, don’t miss out on the festivities! Check out one—or all!—of these events celebrating our great country.
Sydney Opera House
The iconic Sydney Opera House will host an equally iconic lineup of talent for Australia Day. There will be two free concerts January 26—The Wiggles Australia Day Concert and a show more geared towards an older crowd, The Australia Day Concert. While the Wiggles will absolutely be a big hit, the second concert of the day features acts the likes of Jessica Mauboy, James Morrison, The Veronicas, John Foreman, Sheppard, Russel Morris, Justice Crew, David Campbell. Hopefully you already registered for your tickets, because registration for the concerts is closed.
Family fun is the focus of many of Darling Harbour’s offerings on Australia Day. Like the concerts at the Sydney Opera House, performances are free, but these are open to the public. Circus teams from Circusworks will show anyone interest how to juggle, stilt-walk, hula hoops and walk on a balance beam; performers will share Latin, Tibetan and Indigenous sounds with audience members at the Culture Beats Stage; roving performers and buskers and; a Twilight Concert at Cockle Bay. The day at Darling Harbour accumulates in the NSW Australia Day Spectacular: a dazzling extravaganza of fireworks, digital effects, multi-media and music!
The Rocks is providing just as diverse a line-up as Darling Harbour. Enjoy free music performances by fresh Australian talent, wander the Rocks Markets, practice your croquet skills and count down to Triple J’s Hottest 100 on the streets or take in the stunning vista of Sydney Harbour and the Australia Day Harbour activities.
Hyde Park Summer Playground
With plenty of on-stage fun organised by leading entertainment brand for kids and family – Nickelodeon, there’s never a dull moment in the interactive zones set up throughout the park. You’ll find Nickelodeon characters at the meet-and-greet zone, and there are stacks of activities to keep the whole family entertained.
Bring your friends and family down to the harbour for 12pm to Salute to Australia and sing the national anthem in harmony with synchronised choirs. In a grand ceremonial display of respect, Salute to Australia will see the Australian Army, Royal Australian Navy and Royal Australian Air Force combine their efforts to pay tribute to Australia. There are a host of other events, including a concert, cruising concert and the Harbour parade.
Seo JungJin: Who is EY’s World Entrepreneur of 2021?
Seo JungJin, founder of biopharma firm Celltrion, which most recently developed an antibody treatment for COVID-19, has been named the EY World Entrepreneur of the Year 2021, becoming the first South Korean in the award’s 21-year history.
Regarded as one of the world’s most prestigious business awards program for entrepreneurs, the EY Entrepreneur of the Year celebrates visionary and innovative leaders from across 60 countries who are transforming the world and fostering growth.
JungJin, who is now honoroary chairman of Celltrion Group, was up against a worthy cast of entrepreneurial competitors, taking the crown from among 45 award winners across 38 countries and territories.
Speaking during the virtual event, JungJin described his own interpretation of entrepreneurship as something that brings together “a group of people toward a common vision, embracing challenges as opportunities and committing oneself to contribute to the greater good”.
Why was JungJin crowned King Entrepreneur?
A South Korean native and now 63 years of age, JungJin founded biopharmaceutical firm Celltrion in 2003. In the nearly two decades since its founding, Celltrion has lived up to its goal of advancing health and welfare for all by developing ground-breaking drugs to treat autoimmune disease, various forms of cancer and, most recently, COVID-19.
The company, which JungJin started with just US$45,000 and five of his colleagues, has since growth to more than 2,1000 employees with sales permits in more than 90 countries and revenues exceeding US$1.69bn.
According to the panel, JungJin’s story is a shining example of the power of an unstoppable entrepreneur to change the world with the pandel moved by both his incredible story and his purpose-driven leadership, innovative mindset and entrepreneurial spirit.
Described by the chair of the EY judging panel Rosaleen Blair as “representing everything an unstoppable should be” from taking on the world’s biggest health care challenges to consistently creating long-term value for his company, JungJin’s story is one of incredible tenacity and perseverance that the judging panel felt most represented the entrepreneurial spirit.
“He’s taken breathtaking risks, both personal and professional, to found Celltrion and grow it into one of the world’s leading biopharmaceutical companies,” says Stasia Mitchell, EY Global Entrepreneurship Leader. “His passion for creating affordable, life-saving health care and flair for tackling global problems has led to many treatments that have helped millions of people worldwide and was especially evident this past year through the creation of a COVID-19 antibody treatment.”
How did JungJin get there?
JungJin's entrepreneurial journey started at an early age when he worked as a taxi driver to get himself through Konkuk University in Seoul, South Korea. After studying industrial engineering, he rose through the ranks of Daewoo Motor Co. before losing his job amid the carmaker’s financial troubles following the 1997 Asian economic crisis.
Following this, JungJin started collaborating with colleagues to explore business opportunities in different industries, though none delivered lasting success. The turning point came after he attended a talk hosted by renowned scholars, which inspired him to focus on the biopharmaceutical sector.
And so he founded Celltrion with just US$45,000 of his savings. The launch of Remsima, credited with being the world's first antibody biosimilar, quickly moved Celltrion up the ranks of the country's fairly underdeveloped pharmaceutical sector. Celltrion followed this success with the launch of drugs for breast cancer and lymphoma that today are being used worldwide.
With ambitions to be the world’s first in different areas, Celltrion has pioneered numerous uncharted areas to great success over the past two decades, most recently responding to the global pandemic by successfully developing an antibody treatment for COVID-19 and working to ensure a timely supply of the safe and effective treatment.
“When I first started, my vision was to help patients gain access to safe, effective and affordable medicines and thereby enhance the quality of people’s lives,” explains JungJin. “The success of Celltrion has enabled me to expand on this while finding new ways to fuel my entrepreneurial drive.”